Enoxaparin Sodium NDC 55154-3543

Product information

Brand name (proprietary)

Enoxaparin Sodium

Generic name (nonproprietary)

enoxaparin sodium

Active ingredients

Enoxaparin sodium — 100 mg/mL

Dosage form

Injection

Route

Subcutaneous

Labeler

Cardinal Health 107, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 077857

Marketing start

Jul 23, 2010

Listing expires

Dec 31, 2027

Other FDA classes

Low-Molecular-Weight (Chemical structure)

Identifiers

Product ID 55154-3543_5894db55-5339-46b2-9683-4a1d35d4adf4SPL ID 5894db55-5339-46b2-9683-4a1d35d4adf4SPL set ID 5e7568a6-cf8a-4de2-86ba-b94c8ab4c806RxCUI 854228, 854235, 854238, 854241, 854248UNII 8NZ41MIK1OUPC 0055154354059, 0055154354455, 0055154354257, 0055154354158

Pharmacologic class

Low Molecular Weight Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455154354305 followed by a unit qualifier and the quantity Copy

Package 55154-3543-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 077857

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.